Page 4 - J Amp News Today

J&J finalized the biggest shake-up in its 137-year history earlier this month through an exchange of its shares with Kenvue’s, leaving the pharmaceutical giant with a reduced 9.5% stake in its former unit

Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported

Japanese derma brand Dr Ci:Labo’s “breakthrough” retinol products have been underpinned by innovations in delivery system technology.

U.S. Bankruptcy Judge Michael Kaplan ruled that J&J company’s second bankruptcy must, like its first, be dismissed as the company was not in ‘financial distress’

The spot sees a mother and a father tend to their newborn with Johnson’s baby soap.

A California jury awards $18.8 million to a cancer victim in the Johnson & Johnson talc baby powder lawsuit, marking a significant setback for J&J amid mounting talc-related cases.

Johnson & Johnson said it now expects to earn between $10.70 and $10.80 per share on an adjusted basis for 2023, compared with its prior forecast of $10.60 and $10.70

(Reuters) -Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court. The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages. Hernandez, 24, has said he developed mes...

Jury rules Johnson & Johnson must pay $18.8-million to man who claims company’s talc-based product caused his cancer

A US jury ordered Johnson & Johnson to pay $18.8 million to a California man who claimed he developed cancer from their baby powder.